Compare, Analyse Sterling Biotech with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TEVA PHARMA (Israel) - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   TEVA PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TEVA PHARMA
Dec-13
STERLING BIOTECH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs113,001-   
Low Rs32,607-   
Sales per share (Unadj.) Rs26.81,722.1-  
Earnings per share (Unadj.) Rs-15.0107.6-  
Cash flow per share (Unadj.) Rs-5.5246.8-  
Dividends per share (Unadj.) Rs094.18-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs54.91,913.0-  
Shares outstanding (eoy) m267.87848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.6 15.9%   
Avg P/E ratio x-0.526.1 -1.8%  
P/CF ratio (eoy) x-1.311.4 -11.2%  
Price / Book Value ratio x0.11.5 8.6%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,8622,377,546 0.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.332,492.5 16.3%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,029.8 -145.8%   
INCOME DATA
Net Sales Rs m7,1811,460,373 0.5%  
Other income Rs m430-   
Total revenues Rs m7,2231,460,373 0.5%   
Gross profit Rs m947399,924 0.2%  
Depreciation Rs m2,543118,043 2.2%   
Interest Rs m4,37728,684 15.3%   
Profit before tax Rs m-5,931253,197 -2.3%   
Minority Interest Rs m01,150 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-166,210 0.0%   
Tax Rs m-1,924-3,091 62.2%   
Profit after tax Rs m-4,00791,228 -4.4%  
Gross profit margin %13.227.4 48.2%  
Effective tax rate %32.4-1.2 -2,657.5%   
Net profit margin %-55.86.2 -893.2%  
BALANCE SHEET DATA
Current assets Rs m14,335986,331 1.5%   
Current liabilities Rs m49,809860,164 5.8%   
Net working cap to sales %-494.08.6 -5,718.3%  
Current ratio x0.31.1 25.1%  
Inventory Days Days40391 444.3%  
Debtors Days Days17196 177.9%  
Net fixed assets Rs m55,432476,990 11.6%   
Share capital Rs m2683,595 7.5%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,7011,622,198 0.9%   
Long term debt Rs m9,478746,721 1.3%   
Total assets Rs m73,9883,337,421 2.2%  
Interest coverage x-0.49.8 -3.6%   
Debt to equity ratio x0.60.5 140.1%  
Sales to assets ratio x0.10.4 22.2%   
Return on assets %0.53.6 13.9%  
Return on equity %-27.35.6 -484.6%  
Return on capital %-6.44.9 -130.3%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,719232,708 0.7%  
From Investments Rs m-3,148-82,458 3.8%  
From Financial Activity Rs m1,426-279,149 -0.5%  
Net Cashflow Rs m-3-128,899 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare STERLING BIOTECH With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare STERLING BIOTECH With: BIOCON   WOCKHARDT  DR. REDDYS LAB  DR. DATSONS LABS  DIVIS LABORATORIES  



Today's Market

Sensex Ends 82 Points Lower; Energy and Healthcare Stocks Witness Selling(Closing)

Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.

Related Views On News

Most Popular

The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)

Feb 19, 2020

While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.

Here's Why I Recommended 15 Stocks in One Day Flat Views On News (Views On News)

Feb 14, 2020

This proven strategy can give big returns in quick time.

The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)

Feb 18, 2020

Avoid these mistakes and your trading will turn much more profitable.

Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)

Feb 20, 2020

A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.

These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)

Feb 17, 2020

There are Indian stocks which can soar like Tesla in the long-run.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
LIVE NOW!: Equitymaster's Biggest Wealth Creating Project Ever is LIVE. Watch Now!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - WYETH LTD COMPARISON

COMPARE STERLING BIOTECH WITH

OTHER USEFUL LINKS

MARKET STATS